Literature DB >> 19638042

Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.

Katsumi Shigemura1, Tomihiko Yasufuku, Masuo Yamashita, Soichi Arakawa, Masato Fujisawa.   

Abstract

OBJECTIVES: To evaluate the combination of isepamicin and levofloxacin in the prophylaxis of infectious complications associated with prostate biopsy (PBX).
METHODS: A total of 586 patients who underwent transrectal PBX in a single center were included in this retrospective analysis. They received 400 mg isepamicin once just before PBX plus 300 mg oral levofloxacin each day for three days as a rule. Clinical and laboratory data were evaluated.
RESULTS: A total of three (0.51%) patients presented a febrile complication after PBX. All of them were diagnosed as acute prostatitis. Serum white blood cell count and C-reactive protein in the 131 patients whose laboratory data were available for statistical analyses did not rise significantly after PBX.
CONCLUSIONS: Isepamicin plus fluoroquinolone can be considered a valuable regimen for antibiotic prophylaxis of PBX.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638042     DOI: 10.1111/j.1442-2042.2009.02348.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  Efficacy of prophylactic single-dose therapy using fluoroquinolone for prostate brachytherapy.

Authors:  Takeo Nomura; Kenichi Hirai; Mutsushi Yamasaki; Toru Inoue; Mika Takahashi; Takayuki Kawashima; Fuminori Sato; Hiromitsu Mimata
Journal:  Jpn J Radiol       Date:  2012-05       Impact factor: 2.374

2.  Efficacy of combination use of Beta-lactamase inhibitor with penicillin and fluoroquinolones for antibiotic prophylaxis in transrectal prostate biopsy.

Authors:  Katsumi Shigemura; Minori Matsumoto; Kazushi Tanaka; Masuo Yamashita; Soichi Arakawa; Masato Fujisawa
Journal:  Korean J Urol       Date:  2011-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.